Skip to content
ppharmaranks
Menu

EMRELIS vs ROZLYTREK

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. EMRELIS and ROZLYTREK are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

TELISOTUZUMAB VEDOTIN-TLLV
ENTRECTINIB

Dosage forms

Injectable
Capsule, Oral pellets

Drug class

Boxed warning

None
None

Treats

Non-Small-Cell Lung Carcinoma
Non-Small-Cell Lung Carcinoma

Frequently asked questions

Which is better-rated, Emrelis or Rozlytrek?

By our independent rating, Emrelis scores higher — 3.6 vs 3.5 out of 5 for Rozlytrek. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Emrelis and Rozlytrek?

Emrelis contains Telisotuzumab Vedotin-Tllv, while Rozlytrek contains Entrectinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.